0000899243-20-028608.txt : 20201019
0000899243-20-028608.hdr.sgml : 20201019
20201019161523
ACCESSION NUMBER: 0000899243-20-028608
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200528
FILED AS OF DATE: 20201019
DATE AS OF CHANGE: 20201019
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Truitt Joseph
CENTRAL INDEX KEY: 0001452429
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34236
FILM NUMBER: 201246352
MAIL ADDRESS:
STREET 1: C/O ACHILLION PHARMACEUTICALS, INC.
STREET 2: 300 GEORGE STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06511
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOSPECIFICS TECHNOLOGIES CORP
CENTRAL INDEX KEY: 0000875622
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 113054851
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 WILBUR ST
CITY: LYNBROOK
STATE: NY
ZIP: 11563
BUSINESS PHONE: 302-842-8450
MAIL ADDRESS:
STREET 1: 2 RIGHTER PARKWAY, SUITE 200
CITY: WILMINGTON
STATE: DE
ZIP: 19803
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0306
4/A
2020-05-28
2020-05-29
0
0000875622
BIOSPECIFICS TECHNOLOGIES CORP
BSTC
0001452429
Truitt Joseph
C/O BIOSPECIFICS TECHNOLOGIES CORP.
2 RIGHTER PKWY, DELAWARE CORP. CENTER II
WILMINGTON
DE
19803
1
1
0
0
Chief Executive Officer
Stock Option (Right to Buy)
63.72
2020-05-28
4
A
0
100000
0.00
A
2030-05-28
Common Stock
100000
100000
D
The stock options were granted under the BioSpecifics Technologies Corp. 2019 Omnibus Incentive Compensation Plan (the "Plan").
As previously reported on a Form 4 filed on May 29, 2020 by the reporting person, the reporting person reported acquiring stock options to purchase 130,000 shares of common stock. However, BioSpecifics Technologies Corp. (the "Company") subsequently determined that stock options to purchase 30,000 shares of common stock under the Plan were not validly granted pursuant to the Plan because they exceeded the Plan limit on the number of stock options that may be granted to any newly-hired employee participant in any one calendar year. Accordingly, the attempted grant of these excess stock options was ineffective, and they were never granted to the reporting person. The reporting person is filing this amendment to report the correct amount of stock options acquired.
The stock options vest in four equal installments over the four-year period following the date of grant.
/s/ Joseph E. Truitt by Carl A. Valenstein, attorney- in-fact
2020-10-19